Cargando…
The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel
The anthelmintic drug praziquantel (PZQ) is used to treat schistosomiasis, a neglected tropical disease that affects over 200 million people worldwide. PZQ causes Ca(2+) influx and spastic paralysis of adult worms and rapid vacuolization of the worm surface. However, the mechanism of action of PZQ r...
Autores principales: | Park, Sang-Kyu, Gunaratne, Gihan S., Chulkov, Evgeny G., Moehring, Francie, McCusker, Paul, Dosa, Peter I., Chan, John D., Stucky, Cheryl L., Marchant, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901322/ https://www.ncbi.nlm.nih.gov/pubmed/31653697 http://dx.doi.org/10.1074/jbc.AC119.011093 |
Ejemplares similares
-
Activation of host transient receptor potential (TRP) channels by praziquantel stereoisomers
por: Gunaratne, Gihan S., et al.
Publicado: (2018) -
Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel
por: Chulkov, Evgeny G., et al.
Publicado: (2021) -
The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand
por: Chan, John D., et al.
Publicado: (2017) -
Anti-schistosomal action of the calcium channel agonist FPL-64176
por: McCusker, Paul, et al.
Publicado: (2019) -
The Anthelmintic
Activity of Praziquantel Analogs
Correlates with Structure–Activity Relationships at TRPM(PZQ) Orthologs
por: Sprague, Daniel J., et al.
Publicado: (2023)